Drawing for IPSEN BIOPHARMACEUTICALS

USPTO serial 98598966

IPSEN BIOPHARMACEUTICALS

Reviewed by CopyMark Law Group

Status 732Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
KENEALY, NATALIE LANGFORD
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 732: Status 732 means the third six-month extension to file a Statement of Use was granted. You are past the midpoint of available extension time — plan SOU filing carefully.

Need help with IPSEN BIOPHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ben Natter

Ben Natter HAUG PARTNERS, LLP745 FIFTH AVENUENEW YORK, NY 10151United States

Goods and services

ClassDescriptionStatusFirst use
041Training services in the fields of science, health, medicine and beauty; education services, namely, arranging and conducting colloquiums, conferences, educational conventions, seminars, educational symposiums in the fields of science, health, medicine, pharmacy and beautyACTIVE—
042Scientific, medical and industrial research services for new products in the fields of health, medicine, pharmacy and beauty; product research and development services for new products in the fields of science, health, medicine, pharmacy and beauty; product design services for chemical products, proprietary medicines, plants and pharmaceutical procedures in production of pharmacologically active substance and preparations, of cosmetics; scientific testing of chemical products, pharmaceutical products, cosmetic products, chemical, biological and bacteriological analysis; design and development of computer hardware and software, all above mentioned services provided for others; providing advice and consulting in connection with scientific researchACTIVE—
044Medical services; providing hygienic and beauty care services for human beings; providing advice and consulting in connection with the medical, pharmaceutical and cosmetic fields; information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals, providing information about cosmetic beauty care, and providing medical information; providing a website featuring information in the medical, pharmaceutical and cosmetic fields, namely, information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals, information about cosmetic beauty care, and general medical information; medical testingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 5, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 4, 2026EX3GSOU EXTENSION 3 GRANTED—
Sep 4, 2026EXT3SOU EXTENSION 3 FILED—
Sep 4, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 26, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 25, 2026EX2GSOU EXTENSION 2 GRANTED—
Mar 25, 2026EXT2SOU EXTENSION 2 FILED—
Mar 25, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 29, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 29, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 29, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 29, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 29, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 29, 2025EX1GSOU EXTENSION 1 GRANTED—
Aug 29, 2025EXT1SOU EXTENSION 1 FILED—
Aug 29, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 1, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 4, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 4, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 29, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 13, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 13, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Jan 13, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 13, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 13, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 3, 2025DOCKASSIGNED TO EXAMINER—
Jan 2, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 13, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance